NVST - Envista Holdings Corp
Envista Holdings Corporation (NYSE: NVST - Get Free Report) has received a consensus rating of "Hold" from the seventeen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Ten research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 month price
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Keel purchased 4,701 shares at $53.18 each following a 21% year-long decline, signaling confidence in the medical device company's valuation.
BREA, Calif., Oct. 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its third quarter 2026 on Wednesday, November 4, 2026.
VG, HCSG, NVST, EQNR and HMN have been added to the Zacks Rank #1 (Strong Buy) List on September 28, 2026.
Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
SLDE, HHH and NVST made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 21st, 2026.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Envista (NVST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Envista Holdings Corporation (NVST) Analyst/Investor Day Transcript
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Envista Holdings Corporation (NVST) Presents at 2026 Global Healthcare Conference Transcript
Investors interested in Medical - Products stocks are likely familiar with Envista (NVST) and Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
BREA, Calif., Sept. 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2026 Global Healthcare Conference.
Envista (NVST) reported earnings 30 days ago. What's next for the stock?
Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names ranging from Broadcom to Moderna that could reshape your portfolio positioning.
Canada Pension Plan Investment Board acquired a new position in Envista Holdings Corporation (NYSE: NVST) during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 191,353 shares of the company's stock, valued at approximately $5,042,000. Canada Pension Plan Investment Board owned about
Four value stocks stand out as investors look beyond AI, using PEG ratios, earnings growth and valuation metrics to find potential winners.
ONTO, VIRT and NVST made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27th, 2026.